Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis

  • Taking Part in OPTIMA
  • OPTIMA Recruiting Sites
  • The OPTIMA Team
  • Contact Us
  • Taking Part in OPTIMA
    • COVID-19 and OPTIMA
    • About treatment for breast cancer
    • About OPTIMA
    • Who can take part?
    • What's involved in taking part?
    • Patient and public engagement (PPI)
    • More information
    • Is my local hospital recruiting?
    • Privacy Statement
  • OPTIMA Sites
    • COVID-19 and OPTIMA
    • Essential dcuments
    • Newsletters
    • Administering OPTIMA
    • Qualitative Recruitment Study
    • Recruiter training and support
    • Publications
    • OPTIMA governance
  • The OPTIMA Team
  • Contact Us

  • COVID-19 and OPTIMA
  • Essential Documents
  • Newsletters
  • Administering OPTIMA
  • Qualitative Recruitment Study
  • Recruiter training and support
  • Publications
  • OPTIMA Governance

Newsletters

2021

  • OPTIMA Newsletter 2021 02 23
  • OPTIMA Newsletter 2021 01 29

        Archive

        2020

        • OPTIMA Newsletter 2020 12 17
        • OPTIMA Newsletter 2020 11 26
        • OPTIMA Newsletter 2020 10 26
        • OPTIMA Newsletter 2020 09 29
        • OPTIMA Newsletter 2020 08 21
        • OPTIMA Newsletter 2020 07 22
        • OPTIMA Newsletter 2020 06 22
        • OPTIMA Newsletter 2020 05 21
        • OPTIMA Newsletter 2020 04 20
        • OPTIMA Newsletter 2020 03 24
        • OPTIMA Newsletter 2020 02 20
        • OPTIMA Newsletter 2020 01 22

        2019 

        • OPTIMA Newsletter 2019 12 18
        • OPTIMA Newsletter 2019 11 19
        • OPTIMA Newsletter 2019 10 23
        • OPTIMA Newsletter 2019 09 23
        • OPTIMA Newsletter 2019 08 12
        • OPTIMA Newsletter 2019 06 24
        • OPTIMA Newsletter 2019 05 16
        • OPTIMA Newsletter 2019 04 10
        • OPTIMA Newsletter 2019 03 13
        • OPTIMA Newsletter 2019 02 14
        • OPTIMA Newsletter 2019 01 23

        2018 

        • OPTIMA Newsletter 2018 12 01
        • OPTIMA Newsletter 2018 11 01
        • OPTIMA Newsletter 2018 10 03
        • OPTIMA Newsletter 2018 09 01
        • OPTIMA Newsletter 2018 08 01
        • OPTIMA Newsletter 2018 07 01
        • OPTIMA Newsletter 2018 06 06
        • OPTIMA Newsletter 2018 05 01
        • OPTIMA Newsletter 2018 04 01
        • OPTIMA Newsletter 2018 02 21
        • OPTIMA Newsletter 2018 01 25

        2017 

        • OPTIMA Newsletter_2017-12-20
        • OPTIMA Newsletter_2017-11-24
        • OPTIMA Newsletter_2017-10-26
        • OPTIMA Newsletter_2017-09-20
        • OPTIMA Newsletter_2017-08-18
        • OPTIMA Newsletter_2017-06-30
        • OPTIMA Newsletter_2017-05-31

        © 2019 OPTIMA

        ABS Badge The OPTIMA Study is funded by National Institute for Health Research (NIHR), Programme (project reference 10/34/501). The information contained in this website is for general information about the OPTIMA study and is provided by the University of Warwick Clinical Trials Unit & University College London. The views expressed are those of the author(s) and are not necessarily those of NIHR or the Department of Health and Social Care or representative of the views of the funder, sponsor or other participating organisations. Trial Registration Number ISRCTN42400492